Chemokines such as the monocyte chemol attractant protein-1 (MCP-1) convert monocyte rolling to firm arrest under physiological flow conditions via integrin activation and simultaneously activate phosphoinositide 3-kinase (PI3K). Here we used adenoviral gene transfer and biochemical inhibitors to manipulate PI3K-dependent pathways in human monocytes. In in vitro lipid kinase assays from purified human monocytes, we showed that MCP-1 activates the "classical" PI3K␣ pathway and not PI3K␥, a PI3K isoform thought to be activated only by the ␤␥ complex of heterotrimeric G proteins. The activity of PI3K␣ in purified human monocytes was evident within 30 s. MCP-1-induced monocyte arrest was significantly inhibited both by wortmannin (n ‫؍‬ 4; p < 0.01) and LY294002 (n ‫؍‬ 4; p < 0.01) with restoration of the rolling phenotype (p < 0.05 for both inhibitors, compared with rolling of control monocytes after MCP-1 treatment). To test the hypothesis that activation of PI3K is sufficient to induce monocyte adhesion, we transduced the monocytic THP-1 cell line with a recombinant adenovirus (Ad) carrying a constitutively active mutant of PI3K (Ad.BD110). We examined the ability of these cells to adhere to human vascular endothelium (HUVEC) transduced with adenoviruses carrying E-selectin, intercellular adhesion molecule-1 (ICAM-1), and VCAM-1. Under flow conditions, ICAM-1-and VCAM-1-dependent firm adhesion of Ad.BD110-transduced THP-1 cells was enhanced compared with THP-1 cells infected with control Ad (n ‫؍‬ 4; p < 0.01 for both). Adhesion augmented by constitutive PI3K activation was entirely abrogated by pretreatment with wortmannin (n ‫؍‬ 3; p < 0.01). In contrast, a constitutively active Akt construct had no effect on THP-1 adhesion (n ‫؍‬ 3; p ‫؍‬ NS). We conclude that PI3K activation is necessary and sufficient to enhance monocytic adhesion under physiological flow conditions. BD110-expressing THP-1 cells should provide a useful tool for identifying the signaling pathways downstream of PI3K that are necessary for monocyte recruitment relevant to a variety of human vascular pathologies.
Chemokines such as the monocyte chemol attractant protein-1 (MCP-1) convert monocyte rolling to firm arrest under physiological flow conditions via integrin activation and simultaneously activate phosphoinositide 3-kinase (PI3K). Here we used adenoviral gene transfer and biochemical inhibitors to manipulate PI3K-dependent pathways in human monocytes. In in vitro lipid kinase assays from purified human monocytes, we showed that MCP-1 activates the "classical" PI3K␣ pathway and not PI3K␥, a PI3K isoform thought to be activated only by the ␤␥ complex of heterotrimeric G proteins. The activity of PI3K␣ in purified human monocytes was evident within 30 s. MCP-1-induced monocyte arrest was significantly inhibited both by wortmannin (n ‫؍‬ 4; p < 0.01) and LY294002 (n ‫؍‬ 4; p < 0.01) with restoration of the rolling phenotype (p < 0.05 for both inhibitors, compared with rolling of control monocytes after MCP-1 treatment). To test the hypothesis that activation of PI3K is sufficient to induce monocyte adhesion, we transduced the monocytic THP-1 cell line with a recombinant adenovirus (Ad) carrying a constitutively active mutant of PI3K (Ad.BD110). We examined the ability of these cells to adhere to human vascular endothelium (HUVEC) transduced with adenoviruses carrying E-selectin, intercellular adhesion molecule-1 (ICAM-1), and VCAM-1. Under flow conditions, ICAM-1-and VCAM-1-dependent firm adhesion of Ad.BD110-transduced THP-1 cells was enhanced compared with THP-1 cells infected with control Ad (n ‫؍‬ 4; p < 0.01 for both). Adhesion augmented by constitutive PI3K activation was entirely abrogated by pretreatment with wortmannin (n ‫؍‬ 3; p < 0.01). In contrast, a constitutively active Akt construct had no effect on THP-1 adhesion (n ‫؍‬ 3; p ‫؍‬ NS). We conclude that PI3K activation is necessary and sufficient to enhance monocytic adhesion under physiological flow conditions. BD110-expressing THP-1 cells should provide a useful tool for identifying the signaling pathways downstream of PI3K that are necessary for monocyte recruitment relevant to a variety of human vascular pathologies.
In vitro and in vivo models suggest a role for chemokines in a variety of inflammatory pathologies, including asthma, arthritis, and atherosclerosis. As chemoattractants, chemokines play an important role in the directional migration of leukocytes through tissues. Recent data have also underscored the importance of chemokines in enhancing the avidity of leukocyte integrins for locally expressed adhesion molecules. Under physiological flow conditions such as seen in the bloodstream, chemokines can induce the rapid conversion of lymphocyte (1) or monocyte (2) tethering (rolling) to firm adhesion via integrin activation. These data speak to an important role for chemokines in the initial step of leukocyte infiltration of the endothelium, which is then followed by transmigration into the surrounding tissues. However, the pathways by which chemokines activate leukocytes, markedly enhancing leukocyte firm adhesion over the course of seconds, remain poorly understood.
Recently the PI3K 1 family has been implicated in chemokine receptor signaling. Chemokines activate PI3K isoforms in nanomolar concentrations, and biochemical inhibitors of PI3K have been shown to inhibit chemokine-triggered chemotaxis of lymphocytes, NK cells, and monocytes (3) (4) (5) . The PI3K␥ isoform in particular is thought to play an important role in the signaling of G protein-coupled receptors, such as chemokine receptors (5) . Neutrophils from mice deficient in PI3K␥ have diminished chemotaxis to specific chemokines (6 -8) . However, in contrast, neutrophil adhesion induced by several chemokines, is unaffected by the loss of PI3K␥ (6) . In addition, data from other lines of investigation suggest roles for other signaling pathways such as Rho GTPases in chemokine-triggered arrest of leukocytes (6, 9) .
Here we used biochemical inhibitors and adenoviral gene transfer to manipulate PI3K-dependent pathways in human monocytes and studied the functional effects of these manipulations on adhesion under physiological flow conditions. Interestingly, we found that MCP-1 triggered monocyte adhesion and activation of the PI3K␣ isoform, but not PI3K␥ in purified human monocytes. PI3K activation correlated temporally with our functional studies. Furthermore, PI3K was necessary for the chemokine-triggered conversion of monocyte rolling to firm adhesion and sufficient to enhance monocyte arrest under physiological flow conditions. * This work was supported in part by National Institutes of Health Grants HL03348 and HL65584 (to R. E. G.); HL54202, AI40970, and HL59521 (to A. R.); HL61688 and DK50282 (to T. F.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ were isolated and cultured in M199 with 20% fetal bovine serum, endothelial cell growth factor (25 g/ml; Biomedical Technologies, Stoughton, MA), porcine intestinal heparin (50 g/ml; Sigma), and antibiotics. After infection with adenoviral vectors, HUVEC were cultured as above, but the serum concentration was reduced to 10%. For experimental use in the flow plate apparatus, HUVEC (passage 1-2) were plated at confluence in 0.5-cm 2 chambers on fibronectin-coated plastic tissue culture slides. On the day of the flow adhesion assay, a fluorescence immunoassay was performed on HUVEC infected in parallel to document transgene expression and to rule out nonspecific activation of the endothelial monolayer, as previously described (10) . THP-1 cells were obtained from ATCC. 1 ϫ 10 7 cells were infected at an MOI of 25 in 0.5 ml of serum-free RPMI 1640 in a twelve-well dish for 1 h, and the volume was subsequently increased to 3.0 ml and serum added to reach 10%. Experiments were performed and transgene expression was evaluated 24 -48 h after infection.
Recombinant Adenoviruses-AdE-sel (2), AdEGFP (12), AdBD110 (12), and Ad.myr-Akt (12) have been described previously. AdICAM was generated using the system recently described by Wang et al. (11) . Briefly, AdICAM carries the cDNA for human ICAM-1 (kindly provided by Dr. T. A. Springer) and was initially subcloned into the ClaI site in the pLEP shuttle vector. This construct was then linearized and ligated to the pREP vector containing adenoviral (Ad2) backbone. An adenoviral cosmid was then generated employing phage/Escherichia coli extracts (Stratagene). Recombinant adenovirus was generated in 293 cells by lipofectin-mediated transfection with positive cosmid clones. Recombinant adenovirus was propagated by infecting subconfluent 293 cell monolayers in 15-cm tissue culture dishes at an MOI of ϳ10. Stock titers for the various constructs ranged from 1 ϫ 10 10 to 2 ϫ 10 11 pfu/ml with a particle/pfu ratio ranging from 20 to 100. Wild-type adenovirus contamination was excluded by the absence of polymerase chain reaction-detectable E1 sequences.
Monoclonal Antibodies-Antibodies to PI3K were H199 (to PI3K p110␥, Santa Cruz Biotechnology) and 06-195 (to PI3K p85, Upstate Biotechnology); to the Myc epitope were 9E10 (Santa Cruz Biotechnology); to Akt was phospho-Akt-Ser-473 (New England Biolabs). Antibodies to adhesion molecules (10) were 7A9 and H4/18 (to human Eselectin), Hu5/3 (to human ICAM-1), E1/6 (which recognizes both human and rabbit VCAM-1), Rb 1/9 (which recognizes only rabbit VCAM-1), IgG 1 , and IgG 2A control mAb (PharMingen). Antibodies to leukocyte epitopes were CD11b, CD49D, and CD62L (PE labeled from PharMingen).
Flow Cytometry-Monocytes were washed once with RPMI/5% fetal calf serum and incubated with the indicated fluorescent-tagged (nonfluorescein isothiocyanate for EGFP-transduced cells) primary antibodies for 30 -60 min on ice, washed twice with RPMI/5% fetal calf serum, and fixed with 1% formaldehyde. An isotype matched, fluorescentlabeled non-binding antibody was included as a control. Fluorescence was then analyzed using a Becton-Dickinson FACS set to detect fluorescence, forward scatter, and size.
Leukocyte Isolation-Human monocytes were purified from healthy human donors by centrifugation on Ficoll-Hypaque density gradient centrifugation at 15°C (LSM, Organon Teknika, Durham, NC) followed by magnetic bead purification (Miltenyi Biotech). Monocyte suspensions were Ͼ92% pure as determined by light scatter and cell surface antigen analysis.
Adhesion Assays under Flow-We employed a commercially available parallel plate laminar flow chamber (Immunetics, Cambridge, MA). For biochemical inhibitor studies, the monocytes were incubated with the indicated compound or vehicle (Me 2 SO) for 30 min at 16°C and then diluted with perfusion medium to 10 6 cells/ml. Where indicated, chemokines were added to the monocyte reservoir (room temperature). Monocyte rolling (Ͼ3 s) and firm adhesion (Ͼ3 s) were quantified for each coverslip 1 min prior to and 1 min after addition of the chemokine. The cells were perfused at an estimated shear stress of 2.0 dynes/cm 2 (flow rate of 0.78 ml/min). The entire period of perfusion was recorded on videotape.
PI3K Activity-Purified monocytes or THP-1 cells were pretreated with inhibitor or vehicle control. Monocytes were then stimulated with chemokine, and the reaction was stopped with lysis buffer at the indicated time points. Monocyte lysates were immunoprecipitated with mAbs directed at the appropriate PI3K subunit or epitope tag for 4 h at 4°C. PI3K activity was then measured directly using phosphatidylinositol and [␥-32 P]ATP (12) . Phospholipids were then separated by TLC and 32 P-labeled PIP was visualized by autoradiography. PI(4)P standard (Avanti Polar Lipids) was run in parallel.
Statistical Analysis-Data are expressed as the mean Ϯ S.D. or S.E., as indicated. Statistical comparison of means was performed by two-tailed unpaired Student's t test. The null hypothesis was rejected at p Ͻ 0.05.
RESULTS
We first examined the effects of biochemical inhibition of PI3K activity on monocyte adhesion in a parallel-plate laminar flow model. We qualitatively and quantitatively assessed monocyte interactions with HUVEC cells transduced with adenoviruses carrying cDNAs for the human adhesion molecules, E-selectin (AdE-sel) or ICAM-1. The phenotype of persistent monocyte-endothelial interactions was characterized as either rolling or firm arrest at 2.0 dynes/cm 2 . As shown previously, purified human monocytes predominantly rolled on endothelial monolayers transduced with AdE-sel (2). The addition of recombinant MCP-1 (25 nM) to the flow of incoming monocytes, at physiologically relevant concentrations, markedly augmented monocyte adhesion (Fig. 1) , at least in part, though activation of ␤ 1 and ␤ 2 integrins (2), (data not shown). Pretreatment of monocytes with the PI3K inhibitors, wortmannin (10 nM) or the structurally unrelated LY294002 (50 M), significantly reduced monocyte firm adhesion and increased rolling on the monolayers after chemokine treatment. Flow cytometry experiments on purified human monocytes showed no effect of wortmannin (10 nM) or LY294002 (50 M) on surface expression of L-selectin or ␤ 2 integrins (data not shown). As seen in Fig. 1 , we also saw no effect of wortmannin pretreatment on baseline monocyte-endothelial cell interactions under the conditions tested. Effects of wortmannin on monocyte-endothelial cell interactions were seen at 10 nM, suggesting a specific effect on PI3K, rather than 
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nonspecific effects on alternative pathways (13) . Of note, chemokine pretreatment of the endothelial monolayer has no effect on monocyte adhesion in this model (data not shown) (2) .
Chemokines activate several PI3K isoforms in leukocytes, including the classical PI3K␣ (p85/p110, IA) isoform as well as PI3K␥ (p101/p110, IB), which is thought to be activated exclusively by G protein-coupled receptors (3) (4) (5) . We assessed the kinetics and relative activation of PI3K␣ and PI3K␥ in purified human monocytes. As seen in Fig. 2A , MCP-1 activated PI3K␣, and pretreatment of monocytes with low-dose wortmannin (or LY294002, data not shown) markedly attenuated this activity. Though baseline PI3K activity varied, an increase in lipid kinase activity of PI3K␣ was evident within 30 s of MCP-1 stimulation (Fig. 2B) . These data, suggesting rapid activation of the classical PI3K pathway, paralleled our observation that monocyte rolling is converted to firm adhesion in less than 1 min. Interestingly, activity of PI3K␥, previously implicated in chemokine signaling through G protein-coupled receptors (5), was unchanged by MCP-1 at the 30 s and 3 min time points, though background levels were also inhibited by wortmannin. Importantly, the concentration of wortmannin (10 nM) and LY294002 (50 M) necessary for biochemical inhibition in monocytic cells, as seen in Fig. 2C , was comparable with the concentration necessary for functional inhibition.
As biochemical inhibitors suggested that PI3K is necessary for MCP-1-triggered monocyte adhesion, we next used a constitutively active PI3K construct (AdBD110), which employs the p85 binding domain fused in-frame with the p110 catalytic subunit of PI3K␣, to address whether PI3K activation is sufficient to recapitulate the augmented adhesion seen by chemokine activation of monocytes under flow. To manipulate signaling pathways using somatic gene transfer, we employed the monocytic THP-1 cell line, which mimics much of the phenotype of human monocytes (14) . We first assessed lipid kinase activity in vitro of the monocytic THP-1 cell line transduced with the constitutively active PI3K construct. Cell lysates from the transduced THP-1 cells were concentrated using a combination of mAbs, directed at both the c-Myc-tagged BD110 and endogenous p110 proteins. As seen in Fig. 3 , basal activity of uninfected THP-1 cells was low and was unaffected by infection
FIG. 2. Biochemical analysis of PI3K activation.
A, freshly isolated human monocytes (10 6 ) were treated with wortmannin (10 nM, 30 min, 16°C) or vehicle control (similarly diluted Me 2 SO). Monocytes were stimulated with MCP-1 (25 nM) for 3 min and the reaction stopped with lysis buffer. Monocyte lysates were then immunoprecipitated with mAbs directed at either the p85 or p110␥ subunits. PI3K activity was measured directly using phosphatidylinositol and [ 32 P]ATP. Phospholipids were then separated by TLC and 32 P-labeled PIP was visualized by autoradiography. The upper spot co-migrated with the PI(4)P standard (data not shown). B, representative early time points using similar protocol (n ϭ 3). MCP-1 (25 nM) induced an increase in p85-but not p110␥-associated PI3K activity. PI3K activity was inhibited in both cases by wortmannin (10 nM). C and D, PI3K dose-response studies to the inhibitors wortmannin (C) and LY294002 (D). Monocytic THP-1 cells (10 6 ) were treated with the indicated inhibitor, stimulated with MCP-1 (25 nM), and PI3K activity was assessed as above. Spots were cut out from the TLC plate and 32 P-labeled PIP quantitated in a liquid scintillation analyzer (n ϭ 2 for each inhibitor).
FIG. 3. Analysis of PI3K and Akt activation.
An in vitro kinase assay is shown. 2 ϫ 10 6 THP-1 cells were transduced with AdEGFP, AdBD110, AdmyrAkt, (MOI ϭ 25 for each) or left uninfected. After 24 h in culture, cells were lysed with lysis buffer. THP-1 lysates were then immunoprecipitated with mAbs directed at c-Myc and p110 subunits. PI3K activity was then measured directly as described above.
with a control adenoviral construct or an adenovirus carrying the cDNA for a constitutively active Akt construct. In contrast, we saw a marked increase in PI3K activity in the AdBD110-transduced THP-1 cells.
We performed flow cytometry experiments on transduced monocytic cells in parallel with functional assays. We saw no effect of adenoviral gene transfer or PI3K inhibitors on surface expression of integrins critical for monocyte-endothelial interactions or on general markers of leukocyte activation (Fig. 4) . Having confirmed that AdBD110 confers increased PI3K activity, we then investigated the functional consequences of this activity in monocytic cells under dynamic conditions. As seen in Fig. 5 , uninfected and AdEGFP-transduced THP-1 cells show moderate baseline adhesion to HUVEC monolayers co-expressing E-selectin and ICAM-1. Firm adhesion of both uninfected and AdEGFP-transduced THP-1 cells was similarly enhanced by MCP-1 (25 nM). In contrast, we saw approximately a 3-fold increase in baseline ICAM-1-dependent firm adhesion of the BD110-transduced THP-1 cells, to a level comparable with that seen after THP-1 cells are stimulated with MCP-1. In studies employing VCAM-1-transduced monolayers, we also saw augmented adhesion conferred by transduction of THP-1 cells with the BD110 construct (data not shown). Increased adhesion rendered by constitutive PI3K activation and MCP-1 stimulation was inhibited by pretreatment with wortmannin (10 nM). Interestingly, we saw a further increase in overall adhesion after the addition of MCP-1 to the BD110-transduced THP-1 cells.
The serine-threonine kinase Akt is an early critical branching point downstream of PI3K and has been implicated in chemokine-triggered signaling (15, 16) . Its role in protecting cells from apoptosis is well characterized (17) . Akt is also activated by chemokines in a variety of leukocyte subsets in a PI3K-dependent manner and in a time course that could be consistent with a role in the adhesive process (18) . We tested whether Akt, like PI3K, is sufficient to augment adhesion. We employed Ad.myr-Akt an adenovirus containing the cDNA for human Akt rendered constitutively active by the addition of the Src myristoylation signal (12) . As seen in Fig. 6A , MCP-1 rapidly activates Akt in monocytic cells. Transduction of THP-1 cells with BD110 and Ad.myr-akt confers comparable levels of Akt activation as assessed by a mAb specific to Akt phosphorylation at the Ser-473 site. In contrast to PI3K, however, activated Akt did not augment adhesion under flow conditions (Fig. 6B) .
DISCUSSION
Chemokines can markedly enhance leukocyte interactions with surface-expressed adhesion molecules via the rapid activation of integrins, though the relevant signaling pathways remain poorly characterized. Recent in vitro and in vivo data have suggested an important role for PI3K in chemokine signaling, as inhibition of PI3K by biochemical inhibitors and genetic manipulation alter chemotaxis and leukocyte accumulation in several animal models. However, the role of PI3K in leukocyte adhesion under dynamic conditions has not been characterized. The data presented here extend the role of PI3K, as it is necessary for the chemokine-triggered conversion of monocyte rolling to firm arrest, an early step in monocyte recruitment from flowing blood. In addition, our studies also show that PI3K activation is sufficient to augment both ␤ 1 -(binds VCAM-1) and ␤ 2 -(binds ICAM-1) integrin-dependent adhesion. A previous study employing a T cell line transduced with a vaccinia virus carrying a constitutively active PI3K construct showed increased adhesion to an ICAM-1⅐Ig fusion protein under static conditions, though adhesion in their model was not inhibited by PI3K inhibitors such as wortmannin or LY294002 (19) . In contrast, conversion of leukocyte rolling to firm adhesion both by chemokines and AdBD110 was clearly dependent on PI3K in our system. Additionally, we noted that adhesion of THP-1 cells transduced with the constitutively active construct was further augmented by the addition of MCP-1. These data suggest that constitutive activation by this construct is insufficient to saturate all downstream targets or that other signaling pathways can also contribute to augmented firm adhesion. Western blot analysis on lysates from monocytic cells transduced with AdBD110 show little if any further augmentation of Akt activation by the addition of MCP-1 (data not shown), suggesting the latter may be the more likely explanation.
Whereas recent studies of PI3K have underscored its importance in a variety of inflammatory models, they have also underscored our poor understanding of the relevant downstream substrates (20) . Akt is a key signaling branchpoint downstream of PI3K, and we were particularly interested in its potential role in the adhesive process. Data in lower organisms suggest a functional role for an Akt homolog in chemotaxis triggered by cAMP (21) . Correlative data in human neutrophillike HL-60 cells also suggest a role for Akt in chemotaxis to chemokines fMLP and C5a (15) . However, in contrast to a constitutively active PI3K construct, a constitutively active Akt construct was not sufficient to augment adhesion under flow conditions in our model. Studies in knockout mice suggest an important role for PI3K␥ in several in vitro and in vivo inflammatory models, though it should be noted that loss of PI3K␥ had a spectrum of effects on various leukocyte subsets (6 -8) . Other lines of investigation show that PI3K␥ is activated by chemokines in human NK cells, and mAbs directed against this particular isoform, as opposed to mAbs directed at PI3K␣, inhibit NK cell chemotaxis (5) . In this context, it is interesting to note that we did not detect MCP-1-induced activation of PI3K␥ in freshly isolated peripheral human monocytes. Whether the generation of PIP 3 by PI3K isoforms is a general signal for leukocyte activation and migration, or specific PI3K isoforms confer specific downstream signals in individual leukocyte subsets, remains the subject of future investigations.
Data from several lines of investigation, including work in PI3K␥ knockout mice noted previously, now suggest that the signaling pathways necessary for leukocyte chemotaxis differ from those responsible for other functions such as adhesion (2, 22) . The CC chemokine MCP-4, for example, is a potent activator of human monocytes in chemotaxis and calcium flux studies, yet has a negligible effect in modulating leukocyte adhesion under flow. The CXC chemokine, interleukin-8, in contrast, has modest effects in calcium flux and chemotaxis, but is a surprisingly potent agonist for monocyte arrest. Somatic gene transfer, in addition to biochemical inhibitors and transgenic methods, may prove a useful tool to dissect pathways downstream of PI3K in chemokine-activated leukocytes responsible for these potentially distinct signaling mechanisms. Western blot analysis was performed on whole cell lysates using mAbs to phospho-(upper panel) and total Akt (lower panel). B, adhesion studies were performed comparing uninfected, EGFP-, BD110-, or myrAkt-transduced cells in the absence of MCP-1 treatment. As noted previously, Ad.BD110 augmented arrest of THP-1 cells (n ϭ 3; p Ͻ 0.01 compared with uninfected or EGFP-infected cells). Ad.myr-Akt transduction had no effect on THP-1 adhesion under flow (n ϭ 4; p ϭ NS compared with uninfected or EGFP-infected cells).
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